Author: admin
We came across a bullish thesis on The Cooper Companies, Inc. (NASDAQ:COO) on ValueInvestorsClub by dsteiner84. In this article, we will summarize the bulls’ thesis on COO. The company’s shares were trading at $98.10 when this thesis was published, vs. the closing price of $81.22 on Mar 14. A doctor wearing gloves and a mask holding a pair of contact lenses in their hand. COO develops, manufactures, and markets contact lens wearers. It operates through two segments: CooperVison and CooperSurgical. CooperVison toric focuses on spherical, toric and multifocal lenses for correcting vision challenges. CooperSurgical offers women’s health products. CooperVison accounts…
Simba Jonga had access to leading artificial intelligence companies and world-class investors in Silicon Valley, but not to the ideal first customers for his company. He found those customers back in Knoxville, where he graduated from the University of Tennessee in 2022 before attending Stanford University for graduate studies. His platform, an AI-driven app called Laborup, connects skilled manufacturing workers with employers who desperately need them. The company has been called, by Jonga and others, the LinkedIn for blue-collar workers. For those who don’t prefer the term “blue-collar,” Laborup has another term for machine operators and welders: “America’s most critical…
(Bloomberg) — Supply Lines is a daily newsletter that tracks global trade. Sign up here. Most Read from Bloomberg Volkswagen AG has been wanting to build more cars in North America. Now, as Donald Trump embarks on a trade war that’s roiled the global auto industry, the German carmaker’s calculus has grown far more complicated. About this time last year, the company was considering expanding a plant in Tennessee, using a factory it’s planning in South Carolina or boosting operations in Mexico. Executives are now looking primarily at options in the US Southeast, according to people familiar with the matter.…
S&P 500 likely to mount comeback in coming weeks on easing policy uncertainty: UBS Investing.com — The S&P 500’s recent foray into correction territory was unusually quick, but UBS believes the index is likely to make a comeback next month as trade policy uncertainty is expected to ease in the coming weeks. “Once we receive policy clarity, stocks are likely to recover,” analysts at UBS said, expecting the Trump administration to lift trade policy uncertainty in the coming weeks. “We believe it would be politically counterproductive for the Trump administration to pursue policies that risk pushing the economy into recession,”…
(Bloomberg) — Emerging-market assets rose on Monday as traders recalibrate rate cut bets after disappointing economic data releases is the US and news around China stimulus pledge bolstered Asian stocks and commodities. Most Read from Bloomberg US retail sales rose by less than forecast in February and the prior month was revised lower to mark the biggest drop since July 2021. Together with other recent reports, the data bolstered the case for the Federal Reserve to cut rates more aggressively than expected in the months ahead, lifting the currencies of developing countries while bruising the dollar. A gauge of emerging…
(Bloomberg) — Emerging-market assets rose on Monday as traders recalibrate rate cut bets after disappointing economic data releases is the US and news around China stimulus pledge bolstered Asian stocks and commodities. Most Read from Bloomberg US retail sales rose by less than forecast in February and the prior month was revised lower to mark the biggest drop since July 2021. Together with other recent reports, the data bolstered the case for the Federal Reserve to cut rates more aggressively than expected in the months ahead, lifting the currencies of developing countries while bruising the dollar. A gauge of emerging…
More than 18,500 people received Personal Independence Payments (PIP) in October last year to help cope with alcohol-related liver disease, or drug or alcohol misuse – Sam Thomas/Getty Images/iStockphoto Taxpayers are footing a £130m-a-year bill for disability benefit claims linked to alcohol and drug abuse, official statistics show. More than 18,500 people who were eligible for Personal Independence Payment (PIP) in October last year received money to help cope with alcohol-related liver disease, or drug or alcohol misuse, according to the Department for Work and Pensions (DWP). This figure has climbed by almost a third since lockdown, while the number…
A. Lorne Weil; Executive Chairman of the Board of Directors; Inspired Entertainment Inc Brooks Pierce; President, Chief Executive Officer; Inspired Entertainment Inc Patrick Keough; Analyst; Truist Securities Jordan Bender; Analyst; Citizens JMP Securities LLC Ryan Sigdahl; Analyst; Craig Hallum Capital Group Operator Good morning, everyone, and welcome to the Inspired Entertainment fourth quarter 2024 conference call.(Operator Instructions) Please note, today’s event is being recorded.Please refer to the company’s safe harbour statement that appears in the fourth quarter 2024 earnings press release, which is also available in the investor section of the company’s website at www.inceinc.com.This safe harbour statement also applies…
Matthew Duffy; Chief Business Officer; NRX Pharmaceuticals Inc Jonathan Javitt; Chief Scientist, Director; NRX Pharmaceuticals Inc Michael Abrams; Chief Financial Officer; NRX Pharmaceuticals Inc Jason Kolbert; Analyst; D. Boral Capital LLC Thomas Shrader; Analyst; BTIG, LLC Vernon Bernardino; Analyst; H.C. Wainwright & Co., LLC Edward Woo; Analyst; Ascendiant Capital Markets, LLC Operator Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will conduct a question-and-answer session. (Operator Instructions)This call is being recorded on Monday, March 17,…
Matthew Duffy; Chief Business Officer; NRX Pharmaceuticals Inc Jonathan Javitt; Chief Scientist, Director; NRX Pharmaceuticals Inc Michael Abrams; Chief Financial Officer; NRX Pharmaceuticals Inc Jason Kolbert; Analyst; D. Boral Capital LLC Thomas Shrader; Analyst; BTIG, LLC Vernon Bernardino; Analyst; H.C. Wainwright & Co., LLC Edward Woo; Analyst; Ascendiant Capital Markets, LLC Operator Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will conduct a question-and-answer session. (Operator Instructions)This call is being recorded on Monday, March 17,…